Logo for Carmat SA

Carmat Investor Relations Material

Latest events

Logo for Carmat SA

Trading Update

Carmat
Logo for Carmat

H1 2024

6 Sep, 2024
Logo for Carmat

H2 2023

24 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Carmat SA

Access all reports
Carmat SA is a French medical technology company that specializes in the development and manufacturing of advanced artificial heart systems. The company's flagship product is the Aeson, a biocompatible, fully implantable total artificial heart designed to provide a life-saving alternative for patients suffering from end-stage biventricular heart failure. Carmat's innovative heart prosthesis mimics the natural human heart's functions and aims to bridge the gap for patients awaiting heart transplants. Carmat SA is headquartered in Vélizy-Villacoublay, France, and its shares are listed on the Euronext Paris.